PL3585383T3 - Zastosowanie 3-[5-amino-4-(3-cyjanobenzoilo)pirazol-1-ilo]- n-cyklopropylo- 4-metylobenzamidu w zapobieganiu ostrym zaostrzeniom przewlekłej obturacyjnej choroby płuc - Google Patents

Zastosowanie 3-[5-amino-4-(3-cyjanobenzoilo)pirazol-1-ilo]- n-cyklopropylo- 4-metylobenzamidu w zapobieganiu ostrym zaostrzeniom przewlekłej obturacyjnej choroby płuc

Info

Publication number
PL3585383T3
PL3585383T3 PL18819366T PL18819366T PL3585383T3 PL 3585383 T3 PL3585383 T3 PL 3585383T3 PL 18819366 T PL18819366 T PL 18819366T PL 18819366 T PL18819366 T PL 18819366T PL 3585383 T3 PL3585383 T3 PL 3585383T3
Authority
PL
Poland
Prior art keywords
cyanobenzoyl
methylbenzamide
pyrazol
cyclopropyl
prevention
Prior art date
Application number
PL18819366T
Other languages
English (en)
Inventor
Jacqueline PARKIN
Alastair MACKINNON
Original Assignee
Mereo Biopharma 1 Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1720622.8A external-priority patent/GB201720622D0/en
Priority claimed from GBGB1720624.4A external-priority patent/GB201720624D0/en
Priority claimed from GBGB1802354.9A external-priority patent/GB201802354D0/en
Priority claimed from GBGB1802353.1A external-priority patent/GB201802353D0/en
Application filed by Mereo Biopharma 1 Limited filed Critical Mereo Biopharma 1 Limited
Publication of PL3585383T3 publication Critical patent/PL3585383T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL18819366T 2017-12-11 2018-12-11 Zastosowanie 3-[5-amino-4-(3-cyjanobenzoilo)pirazol-1-ilo]- n-cyklopropylo- 4-metylobenzamidu w zapobieganiu ostrym zaostrzeniom przewlekłej obturacyjnej choroby płuc PL3585383T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB1720622.8A GB201720622D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
GBGB1720624.4A GB201720624D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations
GBGB1802354.9A GB201802354D0 (en) 2018-02-13 2018-02-13 Treatment of chronic obstructive pulmonary disease
GBGB1802353.1A GB201802353D0 (en) 2018-02-13 2018-02-13 Treatment of chronic obstructive pulmonary disease
PCT/GB2018/053591 WO2019116022A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
EP18819366.8A EP3585383B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
PL3585383T3 true PL3585383T3 (pl) 2021-07-05

Family

ID=64665365

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18819366T PL3585383T3 (pl) 2017-12-11 2018-12-11 Zastosowanie 3-[5-amino-4-(3-cyjanobenzoilo)pirazol-1-ilo]- n-cyklopropylo- 4-metylobenzamidu w zapobieganiu ostrym zaostrzeniom przewlekłej obturacyjnej choroby płuc

Country Status (12)

Country Link
US (1) US11234967B2 (pl)
EP (2) EP3845228A1 (pl)
JP (1) JP7372680B2 (pl)
KR (1) KR102760007B1 (pl)
AU (1) AU2018381874B2 (pl)
CA (1) CA3085544A1 (pl)
DK (1) DK3585383T3 (pl)
ES (1) ES2882978T3 (pl)
HU (1) HUE054266T2 (pl)
PL (1) PL3585383T3 (pl)
PT (1) PT3585383T (pl)
WO (1) WO2019116022A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2884789T3 (es) 2017-12-11 2021-12-13 Mereo Biopharma 1 Ltd Uso de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-metilbenzamida en el tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
KR102489320B1 (ko) 2022-06-25 2023-01-18 (주)케이셈테크놀러지 외팔보 쿼드 타입 반도체 다이 본딩장치 및 그 본딩방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6598603B1 (en) 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
ES2393950T3 (es) 2003-06-26 2013-01-02 Novartis Ag Inhibidores de la quinasa P38 con base en heterociclos de 5 miembros
TWI439284B (zh) 2004-04-09 2014-06-01 艾伯維生物技術有限責任公司 用於治療TNFα相關失調症之多重可變劑量療法
GB0409703D0 (en) 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
GB0603684D0 (en) 2006-02-23 2006-04-05 Novartis Ag Organic compounds
RU2625762C2 (ru) 2012-03-20 2017-07-18 Новартис Аг Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
KR102762199B1 (ko) * 2016-03-08 2025-02-07 메레오 바이오파마 1 리미티드 만성 폐쇄성 폐 질환의 급성 악화 치료를 위한 투약법

Also Published As

Publication number Publication date
JP7372680B2 (ja) 2023-11-01
EP3585383A1 (en) 2020-01-01
AU2018381874B2 (en) 2024-08-15
ES2882978T3 (es) 2021-12-03
AU2018381874A1 (en) 2020-06-25
KR102760007B1 (ko) 2025-02-03
PT3585383T (pt) 2021-04-21
WO2019116022A1 (en) 2019-06-20
JP2021505630A (ja) 2021-02-18
US20200383950A1 (en) 2020-12-10
KR20200097310A (ko) 2020-08-18
HUE054266T2 (hu) 2021-08-30
DK3585383T3 (da) 2021-04-19
EP3845228A1 (en) 2021-07-07
US11234967B2 (en) 2022-02-01
CA3085544A1 (en) 2019-06-20
EP3585383B1 (en) 2021-03-24

Similar Documents

Publication Publication Date Title
PL3786753T3 (pl) Osobiste drony sensoryczne
ZA201607740B (en) Treatment of the complications of chronic liver disease with caspase inhibitors
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
AP00901S1 (en) Self-service biometric kiosk
PL3433447T3 (pl) Element okładzinowy ścienny lub podłogowy
ZA201405871B (en) Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease
IL247148A0 (en) Pyrazolone compounds and uses thereof
SMT202000117T1 (it) Modificatore di exenatide e suo uso
GB201700340D0 (en) fluid manipulation cartridge and controller mechanism
GB201711190D0 (en) Use of cannabininoids in the treatment of a neurodegenerative disease or disorder
GB201614571D0 (en) Speckle reduction
IL253688A (en) New preparations and methods for the treatment or prevention of chronic obstructive pulmonary diseases
GB201519676D0 (en) Transaction authorisation
IL253800B (en) Trans-2-octanal and its use
MA43533A (fr) Élément de récipient sous pression à construction en duplex
PT3585383T (pt) Utilização de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-n-ciclopropil-4-metilbenzamida na prevenção ou redução de exacerbações graves da doença pulmonar obstrutiva crónica
PL3320901T3 (pl) Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc
HUE055425T2 (hu) 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus elzáródásos tüdõbetegség akut fokozódásának kezelésében
GB201515244D0 (en) Treatment of inflammatory disease or condition
ZA201902263B (en) Helical impeller
GB201720622D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
GB201720624D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations
GB2569412B (en) Chlorination of pyrazolinones
GB201807619D0 (en) Mechatronic drivers in the cold end of a heat pump
GB201802353D0 (en) Treatment of chronic obstructive pulmonary disease